Naftin is a prescription antifungal medication used to treat common skin infections caused by dermatophyte fungi, specifically athlete’s foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis). Its active ingredient, naftifine hydrochloride, belongs to a class of antifungals called allylamines and is applied directly to the skin as a cream or gel.
Conditions Naftin Treats
Naftin targets three related fungal skin infections, all caused by the same family of organisms but appearing on different parts of the body. Athlete’s foot shows up between the toes or across the sole, jock itch affects the groin and inner thighs, and ringworm causes circular, scaly patches on the trunk, arms, or legs. All three involve itching, redness, and flaking skin.
The FDA-approved uses vary slightly depending on the formulation. The 2% cream is approved for all three conditions, while the 2% gel is approved specifically for athlete’s foot between the toes. The 1% versions (both cream and gel) are also used for these infections but are not approved for pediatric patients. The 2% cream can be used in children as young as 2 for ringworm, and in patients 12 and older for athlete’s foot and jock itch.
How Naftin Kills Fungal Cells
Fungal cells rely on a compound called ergosterol to maintain the structure of their cell membranes, similar to the way human cells use cholesterol. Naftifine blocks an enzyme early in the production chain for ergosterol. Without enough ergosterol, the fungal cell membrane weakens and eventually breaks down, killing the organism.
This mechanism is selective. Research comparing the drug’s effect on fungal enzymes versus mammalian enzymes found that naftifine is a potent inhibitor of the fungal version but far less active against the human equivalent. That selectivity is why topical naftifine can destroy the infection without significant harm to your skin cells.
How Well It Works
In two large clinical trials of the 2% gel for athlete’s foot, 59% to 65% of patients achieved a mycological cure, meaning lab tests confirmed the fungus was eliminated. By comparison, only 10% to 14% of patients using the inactive vehicle gel cleared the infection on their own.
Complete cure, a stricter measure requiring both lab-confirmed fungal clearance and full resolution of visible symptoms like redness, itching, and scaling, was reached by 17% to 26% of patients on Naftin versus 2% to 3% on vehicle. That gap between mycological cure and complete cure is typical for antifungal treatments: the fungus can be gone while the skin is still healing. Patients treated with Naftin showed continuous improvement not just during the treatment period but for four weeks after stopping, with the highest response rates appearing at that four-week post-treatment mark.
Available Formulations
Naftin comes in four versions: a 1% cream, a 2% cream, a 1% gel, and a 2% gel. The choice between cream and gel often comes down to the location and type of infection. Creams tend to be more moisturizing and work well on dry, scaly patches. Gels absorb faster and feel less greasy, which can be preferable for areas like the groin or between the toes where moisture buildup is a concern.
How to Apply Naftin
Application schedules depend on the strength and form. The 1% cream is applied once daily. The 1% gel is applied twice daily, morning and evening. Both 2% formulations are applied once daily, covering the affected area plus a half-inch margin of healthy surrounding skin, for two weeks.
Finishing the full course matters. Symptoms like itching and redness often improve within the first two weeks, but stopping early can allow the fungus to survive and symptoms to return. Clinical data shows improvement continues to build even after you stop applying the medication, so what you see during treatment is not the final result.
Side Effects
Because Naftin is applied to the skin rather than taken orally, side effects are generally limited to the application site. The most commonly reported reactions include burning, stinging, dryness, redness, and itching at the treated area. These are typically mild and tend to resolve on their own. Serious systemic side effects are rare with topical use, since very little of the drug is absorbed into the bloodstream.
Use in Children
Naftin’s pediatric approvals are limited and depend on the specific product. The 2% cream is approved for ringworm in children 2 years and older, and for athlete’s foot and jock itch in patients 12 and older. The 2% gel is approved for athlete’s foot in patients 12 and older. Neither the 1% cream nor the 1% gel has been approved for use in children, as safety and effectiveness have not been established in that population for those formulations.